Publications
- Phase 3 randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer2009 | Publication without faculty affiliation
- Duttaroy, Asim, K.: Léčba a klinické studie (Therapy and clinical trials. In: Current Opinion in Lipidology, 2007, 18, s. 384-386)2007 | First Faculty of Medicine
- Primary Aldosteronism and Pregnancy2020 | First Faculty of Medicine
- Prediction of long-term renal denervation efficacy2019 | First Faculty of Medicine, Third Faculty of Medicine
- Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma2019 | First Faculty of Medicine, Third Faculty of Medicine
- Vyjádření výboru Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně k opakovaným nepřesným údajům o riziku osteonekrózy čelisti při antiresorpční léčbě osteoporózy2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- FGF21 Levels in Pheochromocytoma/Functional Paraganglioma2019 | First Faculty of Medicine
- Catecholamines Induce Left Ventricular Subclinical Systolic Dysfunction: A Speckle-Tracking Echocardiography Study2019 | First Faculty of Medicine
- Renální denervace: update2019 | First Faculty of Medicine
- Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis2018 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...